KinDex Pharmaceuticals

Biotechnology, Genetics, Health Care, Medical
Founded in 2009-01-01
Seattle, Washington, United States
http://kindexpharmaceuticals.com/
For Profit

About KinDex Pharmaceuticals

KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders. It was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease. KinDex Pharmaceuticals is developing therapeutics that work through the Bitter Taste Receptors (TAS2Rs), a family of GPCR receptors that target inflammation and metabolic dysfunction.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 6 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 5827274 USD
  • Last Funding: 327274 USD (Debt Financing)
  • Funding Status: Early Stage Venture

Technology Stack

KinDex Pharmaceuticals actively uses 6 products in their tech stack.

Market Presence

Industries: Biotechnology, Genetics, Health Care, Medical

Headquarters: Seattle, Washington, United States